Erasca, Inc. - ERAS

SEC FilingsOur ERAS Tweets

About Gravity Analytica

Recent News

  • 06.10.2025 - 46th Annual Goldman Sachs Global Healthcare Conference
  • 06.10.2025 - 46th Annual Goldman Sachs Global Healthcare Conference
  • 06.02.2025 - Erasca Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001
  • 06.02.2025 - Erasca Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001
  • 05.29.2025 - Erasca to Present at Upcoming Investor Conferences in June
  • 05.29.2025 - Erasca to Present at Upcoming Investor Conferences in June
  • 05.14.2025 - BofA Securities Health Care Conference 2025
  • 05.14.2025 - BofA Securities Health Care Conference 2025
  • 05.13.2025 - Erasca Reports First Quarter 2025 Business Updates and Financial Results
  • 05.13.2025 - Erasca Reports First Quarter 2025 Business Updates and Financial Results

Recent Filings

  • 05.15.2025 - 144 Report of proposed sale of securities
  • 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.13.2025 - EX-99.1 EX-99.1
  • 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.13.2025 - 8-K Current report